Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study

Ru Li, Xue Li, Xiaoxia Zhu, Shengyun Liu, Xiao Zhang, Changhao Xie, Zili Fu, Anbin Huang, Lingyun Sun, Dongzhou Liu, Jinxia Zhao, Ling Wu, Zhanguo Li

Open source

DOI
10.1016/j.jaut.2026.103578
Published
2026-06
Container
Journal of Autoimmunity
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaut.2026.103578,
  title = {Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study},
  author = {Ru Li and Xue Li and Xiaoxia Zhu and Shengyun Liu and Xiao Zhang and Changhao Xie and Zili Fu and Anbin Huang and Lingyun Sun and Dongzhou Liu and Jinxia Zhao and Ling Wu and Zhanguo Li},
  year = {2026},
  journal = {Journal of Autoimmunity},
  doi = {10.1016/j.jaut.2026.103578},
  url = {https://doi.org/10.1016/j.jaut.2026.103578}
}

RIS

TY  - JOUR
TI  - Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study
AU  - Ru Li
AU  - Xue Li
AU  - Xiaoxia Zhu
AU  - Shengyun Liu
AU  - Xiao Zhang
AU  - Changhao Xie
AU  - Zili Fu
AU  - Anbin Huang
AU  - Lingyun Sun
AU  - Dongzhou Liu
AU  - Jinxia Zhao
AU  - Ling Wu
AU  - Zhanguo Li
PY  - 2026
JO  - Journal of Autoimmunity
DO  - 10.1016/j.jaut.2026.103578
UR  - https://doi.org/10.1016/j.jaut.2026.103578
ER  - 

APA

Li, R., Li, X., Zhu, X., Liu, S., Zhang, X., Xie, C., Fu, Z., Huang, A., Sun, L., Liu, D., Zhao, J., Wu, L., & Li, Z. (2026). Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study. Journal of Autoimmunity. https://doi.org/10.1016/j.jaut.2026.103578

Source records